Education
About Us
Working with TipRanks
Follow Us
QuantumPharm, Inc. (HK:2228)
:2228
2228 Stock Chart & Stats
HK$11.36
-HK$0.15(-3.03%)
At close: 4:00 PM EST
HK$11.36
-HK$0.15(-3.03%)
Day’s Range― - ―
52-Week RangeHK$3.05 - HK$15.12
Previous CloseN/A
Volume31.51M
Average Volume (3M)143.30M
Market Cap
HK$48.17B
Enterprise ValueHK$15.51B
Total Cash (Recent Filing)HK$5.32B
Total Debt (Recent Filing)HK$366.10M
Price to Earnings (P/E)―
Beta0.90
Next Earnings
Mar 27, 2026EPS EstimateN/A
Last Dividend Ex-Date
Jun 13, 2016Dividend YieldN/A
Share Statistics
EPS (TTM)0.02
Shares Outstanding4,302,922,000
10 Day Avg. Volume160,836,692
30 Day Avg. Volume143,301,077
Financial Highlights & Ratios
PEG Ratio0.00
Price to Book (P/B)2.72
Price to Sales (P/S)40.47
P/FCF Ratio-20.09
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering0
Bulls Say, Bears Say
Bulls Say
Revenue GrowthXtalPi leverages its proprietary AI-powered R&D platform to deliver stable and accelerating revenue growth across two core business areas: drug discovery and intelligent robotics.
Strategic PartnershipsXtalPi's expanding ecosystem of partnerships reflects its strong commercialization potential across AI and robotics-enabled industries.
Bears Say
R&D Pipeline RisksRisks include potential delays in partnered R&D pipelines, uncertainty in commercialization sustainability, and possible sell-off following lock-up expiry.
QuantumPharm, Inc. News
2228 FAQ
What was QuantumPharm, Inc.’s price range in the past 12 months?
QuantumPharm, Inc. lowest stock price was HK$3.05 and its highest was HK$15.12 in the past 12 months.
What is QuantumPharm, Inc.’s market cap?
QuantumPharm, Inc.’s market cap is HK$48.17B.
When is QuantumPharm, Inc.’s upcoming earnings report date?
QuantumPharm, Inc.’s upcoming earnings report date is Mar 27, 2026 which is in 145 days.
How were QuantumPharm, Inc.’s earnings last quarter?
QuantumPharm, Inc. released its earnings results on Aug 27, 2025. The company reported HK$0.016 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.016.
Is QuantumPharm, Inc. overvalued?
According to Wall Street analysts QuantumPharm, Inc.’s price is currently Overvalued.
Does QuantumPharm, Inc. pay dividends?
QuantumPharm, Inc. pays a Notavailable dividend of HK$0.007 which represents an annual dividend yield of N/A. See more information on QuantumPharm, Inc. dividends here
What is QuantumPharm, Inc.’s EPS estimate?
QuantumPharm, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does QuantumPharm, Inc. have?
QuantumPharm, Inc. has 4,302,922,000 shares outstanding.
What happened to QuantumPharm, Inc.’s price movement after its last earnings report?
QuantumPharm, Inc. reported an EPS of HK$0.016 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -0.676%.
Which hedge fund is a major shareholder of QuantumPharm, Inc.?
Currently, no hedge funds are holding shares in HK:2228
QuantumPharm, Inc. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
29.62%
12-Months-Change
Fundamentals
Return on Equity
-3.55%
Trailing 12-Months
Asset Growth
76.34%
Trailing 12-Months
Company Description
QuantumPharm, Inc.
QuantumPharm, Inc. (2228) is a biotechnology company focused on developing innovative therapeutics for complex diseases through advanced quantum computing and AI-driven drug discovery. Operating primarily in the pharmaceutical sector, the company specializes in precision medicine, targeting treatments for conditions such as cancer, neurological disorders, and rare diseases. QuantumPharm harnesses cutting-edge technology to streamline the drug development process, significantly reducing time to market and increasing the efficacy of its therapeutic solutions.
Technical Analysis
WuXi XDC Cayman, Inc.
―
Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H
―
Hightide Therapeutics Inc
―
RoboSense Technology Company., Ltd
―
Qyuns Therapeutics Co., Ltd. Class H
―
Options Prices
Currently, No data available
---